Ipamorelin

Price range: £24.99 through £67.47

Selective GH secretion observed without concurrent elevation of cortisol or prolactin in preclinical neuroendocrine models — distinguishing it from earlier GHRPs such as GHRP-2 and GHRP-6
Pulsatile growth hormone release patterns documented in binding assays and animal models, with support for lean muscle maintenance and fat metabolism through GH/IGF-1 pathway activation
Bone mineral density interactions and somatotropic axis modulation studied in rodent models with favourable selectivity profiles, alongside potential sleep quality improvements via GH-related mechanisms

Choose Option

Clear

Selective pentapeptide GH secretagogue and ghrelin receptor (GHS-R1a) agonist, originally developed by Novo Nordisk and widely studied for its ability to stimulate GH release with a high degree of receptor selectivity
Investigated in neuroendocrine research for its minimal effect on cortisol, prolactin, and ACTH secretion relative to other GH secretagogues — providing a precise, clean research tool for isolating the GH pathway
Studied for pulsatile GH release patterns, bone mineral density interactions, gut motility, and somatotropic axis regulation in controlled preclinical models
Lyophilised · ≥99% purity · Third-party HPLC & mass spectrometry verified · COA per batch